Follow us for updates
© 2022
Read the Story →

U.S. Sending 2.58 Million More Pfizer Vaccines to the Philippines

Over 9 million doses donated in total.
by Reuters
Sep 17, 2021
Photo/s: Shutterstock

The U.S. government will begin shipping 2.58 million more doses of COVID-19 vaccine to the Philippines on Thursday through the COVAX global distribution program, a White House official said on Thursday.

The latest shipments of vaccines made by Pfizer Inc and Germany's BioNTech bring the total number of vaccines sent to the Philippines to just over 9 million, the official said.

READ: Thanks, Joe and Kamala: Philippines Getting More Vaccines from U.S.

Scientific teams and legal and regulatory authorities from both countries worked together to ensure prompt delivery of safe and effective vaccine lots to the Asian nation, the official added.

Last week, U.S. President Joe Biden's national security adviser Jake Sullivan met with the foreign and defense ministers of the Philippines during their visit to Washington to mark the 70th anniversary of the two countries' Mutual Defense Treaty.

At the time, Sullivan announced that the United States would provide an additional $11.3 million (about P565.6 million) in COVID-19 assistance to the Philippines, bringing total U.S. COVID-19 assistance to the Philippines since the start of the pandemic to $37 million, in addition to the millions of vaccine doses donated.

Continue reading below ↓
Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.